OmniAb (NASDAQ:OABIW) Stock Price Up 19.2% – Here’s What Happened

OmniAb, Inc. (NASDAQ:OABIW) shares traded up 19.2% on Tuesday. The stock traded as high as $0.24 and last traded at $0.2920. Approximately 394 shares were traded during trading, a decline of 98% from the average daily volume of 16,031 shares. The stock had previously closed at $0.2450.

OmniAb Price Performance

The business’s fifty day moving average is $0.26 and its two-hundred day moving average is $0.15.

Institutional Investors Weigh In On OmniAb

An institutional investor recently bought a new stake in OmniAb stock. State Street Corp purchased a new stake in shares of OmniAb, Inc. (NASDAQ:OABIW) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,133,549 shares of the company’s stock, valued at approximately $5,249,000.

OmniAb Company Profile

OmniAb, Inc is a biotechnology company that develops antibody discovery technologies for the biopharmaceutical industry. Its platform is designed to help pharmaceutical and biotechnology companies identify therapeutic antibodies, including fully human and humanized antibodies, for potential use in treating diseases.

The company’s technology is based primarily on genetically engineered animal platforms that support the discovery of antibodies with targeted characteristics. Its offerings have included OmniRat, OmniMouse, OmniChicken, OmniFlic and OmniClic systems, which are intended to generate diverse antibody candidates against challenging biological targets.